| |
Article Title |
Author(s) |
Type |
Pages |
|
American Gastroenterological Association medical position statement: Guidelines for the evaluation and management of chronic diarrhea
June 1999 (Vol. 116 | No. 6 | Pages 1461-1463)
|
|
Full-length article
|
1461-1463
|
|
American Gastroenterological Association Medical Position Statement on the Management of Gastroesophageal Reflux Disease
October 2008 (Vol. 135 | No. 4 | Pages 1383-1391.e5)
|
Peter J. Kahrilas,
Nicholas J. Shaheen,
Michael F. Vaezi
|
Full-length article
|
1383-1391.e5
|
|
AGA Institute Medical Position Statement on Acute Pancreatitis
May 2007 (Vol. 132 | No. 5 | Pages 2019-2021)
|
John Baillie
|
Full-length article
|
2019-2021
|
|
American Gastroenterological Association Medical Position Statement on the Management of Barrett's Esophagus
March 2011 (Vol. 140 | No. 3 | Pages 1084-1091)
|
American Gastroenterological Association
|
Full-length article
|
1084-1091
|
|
Screening and Surveillance for the Early Detection of Colorectal Cancer and Adenomatous Polyps, 2008: A Joint Guideline From the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology
May 2008 (Vol. 134 | No. 5 | Pages 1570-1595)
|
Bernard Levin,
David A. Lieberman,
Beth McFarland,
Kimberly S. Andrews,
Durado Brooks,
John Bond,
Chiranjeev Dash,
Francis M. Giardiello,
Seth Glick,
David Johnson,
C. Daniel Johnson,
Theodore R. Levin,
Perry J. Pickhardt,
Douglas K. Rex,
Robert A. Smith,
Alan Thorson,
Sidney J. Winawer,
American Cancer Society Colorectal Cancer Advisory Group,
US Multi-Society Task Force,
American College of Radiology Colon Cancer Committee
et al.
|
Full-length article
|
1570-1595
|
|
American Gastroenterological Association medical position statement: Evaluation of liver chemistry tests, This document presents the official recommendations of the American Gastroenterological Association (AGA) on the Evaluation of Liver Chemistry Tests. It was approved by the Clinical Practice Committee on March 3, 2002 and by the AGA Governing Board on May 19, 2002.
October 2002 (Vol. 123 | No. 4 | Pages 1364-1366)
|
|
Miscellaneous
|
1364-1366
|
|
Pancreatitis, Pancreatic, and Thyroid Cancer With Glucagon-Like Peptide-1–Based Therapies
July 2011 (Vol. 141 | No. 1 | Pages 150-156)
|
Michael Elashoff,
Aleksey V. Matveyenko,
Belinda Gier,
Robert Elashoff,
Peter C. Butler
et al.
|
Full-length article
|
150-156
|
|
Risk Factors for Progression of Low-Grade Dysplasia in Patients With Barrett's Esophagus
October 2011 (Vol. 141 | No. 4 | Pages 1179-1186.e1)
|
Sachin Wani,
Gary W. Falk,
Jane Post,
Lisa Yerian,
Matthew Hall,
Amy Wang,
Neil Gupta,
Srinivas Gaddam,
Mandeep Singh,
Vikas Singh,
Keng–Yu Chuang,
Vikram Boolchand,
Hemanth Gavini,
John Kuczynski,
Priti Sud,
Ajay Bansal,
Amit Rastogi,
Sharad C. Mathur,
Patrick Young,
Brooks Cash,
John Goldblum,
David A. Lieberman,
Richard E. Sampliner,
Prateek Sharma
et al.
|
Full-length article
|
1179-1186.e1
|
|
American Gastroenterological Association Institute Medical Position Statement on Corticosteroids, Immunomodulators, and Infliximab in Inflammatory Bowel Disease
March 2006 (Vol. 130 | No. 3 | Pages 935-939)
|
Gary R. Lichtenstein,
Maria T. Abreu,
Russell Cohen,
William Tremaine
|
Full-length article
|
935-939
|
|
American Gastroenterological Association medical position statement: Guidelines on intestinal ischemia
May 2000 (Vol. 118 | No. 5 | Pages 951-953)
|
|
Full-length article
|
951-953
|
